Table I.
Sample | Glycan structure | Relative amount | Illustrationa |
---|---|---|---|
Tn-PSM | GalNAcα1-Ser/Thr | 100 | |
Tri-PSMb | GalNAcα1-Ser/Thr | 28 | |
Galβ1-3GalNAcα1-Ser/Thr | 26 | ||
Fucα1-2Galβ1-3GalNAcα1-Ser/Thr | 46 | ||
STn-OSM | NeuNAcα2-6GalNAcα1-Ser/Thr | 100 | |
Tn-MUC1 | GalNAcα1-Ser/Thr | 100 | |
STn-MUC1 | NeuNAcα2-6GalNAcα1-Ser/Thr | 100 | |
T-MUC1 | Galβ1-3GalNAcα1-Ser/Thr | 100 | |
ST-MUC1 | NeuNAcα2-3Galβ1-3GalNAcα1-Ser/Thr | 100 |
aSymbols used:
b~35–50% of these glycan structures will have the Neu5Gc residue attached to the C6 position of the peptide-linked GalNAc residue (Gerken and Jentoft 1987).